Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

225
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
225
Positron Emission Tomography01:29

Positron Emission Tomography

4.5K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.5K
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

146
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
146

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

European urology·2026
Same author

Is there a role for early SSTR-targeting PRRT in GEP-NET?

European journal of nuclear medicine and molecular imaging·2026
Same author

3D-ring CZT gamma cameras in theranostics: is it a revolution?

EJNMMI reports·2026
Same author

Phase 1 Study of [<sup>177</sup>Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy.

Seminars in nuclear medicine·2025
Same author

Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025

Related Experiment Video

Updated: Aug 27, 2025

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

18.0K

PET Imaging Using Gallium-68 (68Ga) RM2.

Heying Duan1, Andrei Iagaru1

  • 1Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, 300 Pasteur Drive, H2200, Stanford, CA 94305, USA.

PET Clinics
|September 24, 2022
PubMed
Summary
This summary is machine-generated.

Gallium-68 (68Ga) RM2 offers a new PET imaging option for prostate cancer detection targeting gastrin-releasing peptide receptors (GRPR). While sensitive, its uptake patterns differ from other agents, highlighting prostate cancer

Keywords:
(68)Ga-RM2BombesinGRPRPETProstate cancer

More Related Videos

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

520
Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging
07:26

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging

Published on: November 20, 2018

6.6K

Related Experiment Videos

Last Updated: Aug 27, 2025

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

18.0K
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

520
Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging
07:26

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging

Published on: November 20, 2018

6.6K

Area of Science:

  • Molecular imaging
  • Nuclear medicine
  • Oncology

Background:

  • Molecular imaging is crucial for personalized medicine, with new theragnostic agents enabling simultaneous imaging and treatment.
  • Gastrin-releasing peptide receptors (GRPR) are significantly overexpressed in prostate cancer, making them a key target.
  • Gallium-68 (68Ga) RM2, a GRPR antagonist, demonstrates high sensitivity and specificity for detecting primary and recurrent prostate cancer.

Purpose of the Study:

  • To review the background, current status, and future perspectives of Positron Emission Tomography (PET) imaging using 68Ga-RM2.
  • To discuss the role of 68Ga-RM2 in the context of emerging theragnostic approaches for prostate cancer.

Main Methods:

  • Review of existing literature on 68Ga-RM2 for PET imaging in prostate cancer.
  • Comparative analysis of 68Ga-RM2 uptake patterns with established agents like 68Ga-PSMA11 and 18F-DCFPyL.

Main Results:

  • 68Ga-RM2 shows promise for sensitive and specific detection of prostate cancer.
  • A notable discordance in uptake patterns exists between 68Ga-RM2 and other common agents (68Ga-PSMA11, 18F-DCFPyL).
  • This discordance reflects the inherent heterogeneity in prostate cancer tumor biology.

Conclusions:

  • 68Ga-RM2 represents a valuable addition to the molecular imaging armamentarium for prostate cancer.
  • Understanding its unique uptake patterns is essential for accurate interpretation and clinical application.
  • Further research is needed to fully elucidate its theragnostic potential and optimize its use in personalized medicine.